Publications by authors named "Ashley Pitcher"

Claim this Profile
I
Identification of potentially undiagnosed patients with nontuberculous mycobacterial lung disease using machine learning applied to primary care data in the UK.
Orla M Doyle, Roald van der Laan, Marko Obradovic, Peter McMahon, Flora Daniels, Ashley Pitcher

Eur Respir J· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A modeling framework for the economic evaluation of baricitinib in moderate-to-severe rheumatoid arthritis.
Max Schlueter, Peter Rouse, Ashley Pitcher, Peita Louise Graham-Clarke, Claudia Nicolay

Expert Rev Pharmacoecon Outcomes Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mathematical modeling of hepatitis c virus (HCV) prevention among people who inject drugs: A review of the literature and insights for elimination strategies.
Ashley B Pitcher, Annick Borquez, Britt Skaathun, Natasha K Martin

J Theor Biol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating drug cost per responder and number needed to treat associated with lixisenatide on top of glargine when compared to rapid-acting insulin intensification regimens on top of glargine, in patients with type 2 diabetes in the UK, Italy, and Spain.
Marion Afonso, Fay Ryan, Ashley Pitcher, Elisheva Lew

J Med Econ· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of Regorafenib for Gastrointestinal Stromal Tumour (GIST) in Germany.
David Tamoschus, Katja Draexler, Jane Chang, Christopher Ngai, Matthew Madin-Warburton, Ashley Pitcher

Clin Drug Investig· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit/hyperactivity disorder in adult patients.
Chris Bushe, Kathleen Day, Victoria Reed, Kristina Karlsdotter, Lovisa Berggren, Ashley Pitcher

J Psychopharmacol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden.
Sten Fredrikson, Euan McLeod, Nathaniel Henry, Ashley Pitcher, Julia Lowin

J Med Econ· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal control of hepatitis C antiviral treatment programme delivery for prevention amongst a population of injecting drug users.
Natasha K Martin, Ashley B Pitcher, Peter Vickerman, Anna Vassall, Matthew Hickman

PLoS One· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis